DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $249,231 | -26.2% | 12,081 | +5.5% | 0.00% | – |
Q2 2023 | $337,919 | +25.2% | 11,451 | -2.3% | 0.00% | – |
Q1 2023 | $269,983 | -26.8% | 11,718 | -11.6% | 0.00% | – |
Q4 2022 | $368,649 | +3.3% | 13,256 | +14.0% | 0.00% | – |
Q3 2022 | $357,000 | +11.6% | 11,625 | +6.8% | 0.00% | – |
Q2 2022 | $320,000 | +23.6% | 10,883 | 0.0% | 0.00% | – |
Q1 2022 | $259,000 | -51.9% | 10,883 | -9.9% | 0.00% | – |
Q4 2021 | $539,000 | -50.8% | 12,081 | -44.3% | 0.00% | -100.0% |
Q3 2021 | $1,095,000 | -66.9% | 21,708 | -48.5% | 0.00% | -66.7% |
Q2 2021 | $3,304,000 | +50.9% | 42,121 | +9.8% | 0.00% | +50.0% |
Q1 2021 | $2,190,000 | +40.8% | 38,355 | +106.6% | 0.00% | 0.0% |
Q4 2020 | $1,555,000 | +247.9% | 18,567 | +48.9% | 0.00% | +100.0% |
Q3 2020 | $447,000 | +40.6% | 12,468 | -5.1% | 0.00% | – |
Q2 2020 | $318,000 | -33.5% | 13,139 | -51.8% | 0.00% | – |
Q1 2020 | $478,000 | +101.7% | 27,246 | +100.5% | 0.00% | – |
Q4 2019 | $237,000 | +0.4% | 13,587 | -12.0% | 0.00% | – |
Q3 2019 | $236,000 | – | 15,435 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |